J&J not participating in Medicines Patent Pool

The Medicines Patent Pool said Johnson & Johnson (NYSE:JNJ) decided not to license patents covering the pharma's HIV drugs to the pool for use in developing countries. The pool, established last year by UNITAID, allows companies to obtain a license to market generic versions of patented HIV/AIDS drugs in developing countries. ...